MedPath

Identification of Anaphylactogenic Antibodies in Peanut Allergy

Conditions
Peanut Allergy
Registration Number
NCT02821286
Lead Sponsor
University of Zurich
Brief Summary

This project intends the analysis and profiling of specific antibodies against major peanut allergens in peanut allergic individuals and molecular cloning of human antibodies against major peanut allergens.

Detailed Description

* Characterization of patient samples reactivity (sera obtained from blood) against major peanut allergens.

* Isolation of antibody-producing B cells.

* Molecular cloning of peanut-specific antibodies from antibody gene sequences obtained from B cells.

* Biophysical and functional characterization of isolated antibodies

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Participants have a described clinical history of peanut allergy and/or are sensitized to peanut allergens (as evidenced by positive skin prick test and allergen-specific IgE testing)
  • Male and female subjects older than 3 years
  • Written informed consent
Read More
Exclusion Criteria
  • age below three years
  • patients suffering from any disease where blood withdrawals might impact the patients' health status such as known anemia.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysis and profiling of specific antibodies against major peanut allergens in samples derived from peanut allergic patients.June 2016 to May 2018
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath